France· FR:64362325
METOPIMAZINE VENIPHARM 15 mg, gélule
A metopimazine product containing métopimazine, registered in France by VENIPHARM, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Price per daily dose
What a daily dose of metopimazine costs, country by country.
Normalised to the WHO defined daily dose (15 mg), so markets compare like for like.
- France: $0.25 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Metopimazine · price per daily dose (15 mg)
USD · FX 28 Sept 2026
- FR France$0.25
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MÉTOPIMAZINE
- Manufacturer
- VENIPHARM
- Country
- France (FR)
- ATC code
- A04AD05
- ATC class
- Metopimazine
- Defined daily dose
- 15 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930305904plaquette(s) aluminium PVC PVDC de 20 gélule(s)EUR 2.77
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A04AD05
Metopimazine, as other registers publish it.
- FranceISALIA 7,5 mg SANS SUCRE, comprimé orodispersible édulcoré à l’aspartamVENIPHARM
- FranceMETOPIMAZINE ARROW 7,5 mg SANS SUCRE, comprimé orodispersible édulcoré à l’aspartamARROW GENERIQUES
- FranceMETOPIMAZINE ARROW CONSEIL 7,5 mg SANS SUCRE, comprimé orodispersible édulcoré à l’aspartamARROW GENERIQUES
- FranceMETOPIMAZINE BIOGARAN CONSEIL 7,5 mg SANS SUCRE, comprimé orodispersible édulcoré à l’aspartamBIOGARAN
- FranceMETOPIMAZINE VENIPHARM 7,5 mg SANS SUCRE, comprimé orodispersible édulcoré à l’aspartamVENIPHARM
- FranceMETOPIMAZINE VIATRIS CONSEIL 7,5 mg SANS SUCRE, comprimé orodispersible édulcoré à l’aspartamVIATRIS SANTE
- FranceVOGALENE 0,1 %, solution buvable en flaconTEVA SANTE
- FranceVOGALENE 10 mg/1 ml, solution injectable en ampouleTEVA SANTE
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/82ed6ea8-8a5c-4fa7-aaf1-551d438b6f3a GET /v1/drugs/82ed6ea8-8a5c-4fa7-aaf1-551d438b6f3a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64362325",
"date_amm": "2024-11-19",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "MÉTOPIMAZINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about metopimazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.